Skip to main content

Closed

IMRX: Immuneering Corporation Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

17thpctl

Volume

0.27×avg

Market Cap

149.93MUSD

P/E Ratio

-3.5TTM

Div Yield

-ann

Immuneering Corporation

IMRXNASDAQ Global Market·USD·Closed

Immuneering Corporation

IMRXNASDAQ·USD·Closed

$4.13

−2.36%

$4.13

−$0.10 (2.36%)

52W Range

17thpctl

Volume

0.27×avg

Mkt Cap

149.93MUSD

P/E

-3.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings